Pancreatic Cancer Research

ResearcherKanazawa UniversityActive in the last 2 years

Shinji Miwa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5962-8287; OpenAlex author ID A5010692199. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2013: 2 papers · 2014: 5 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 10

  1. Ivermectin Combined With Recombinant Methioninase (rMETase) Synergistically Eradicates MiaPaCa-2 Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.17396↗
  2. Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sp… Co-author DOI 10.21873/anticanres.17828↗
  3. Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cell… Co-author DOI 10.21873/cgp.20475↗
  4. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). Co-author DOI 10.1002/jcb.24769↗
  5. Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. First author DOI 10.1002/jcb.24837↗
  6. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models. Co-author DOI 10.1371/journal.pone.0099977↗
  7. The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. Co-author DOI 10.1371/journal.pone.0103382↗
  8. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenogra… Co-author DOI 10.18632/oncotarget.2641↗
  9. Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Co-author DOI 10.4161/cc.25872↗
  10. Single cell time-lapse imaging of focus formation by the DNA damage-response protein 53BP1 after UVC irradiation of human pancreatic cancer cells. Co-author PMID 23564775↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert M. Hoffman · 10 shared papers, 2013–2025 · strength 0.84
  2. Michael Bouvet · 9 shared papers, 2013–2025 · strength 0.64
  3. Sei Morinaga · 3 shared papers, 2024–2025 · strength 0.60
  4. Shuya Yano · 7 shared papers, 2013–2014 · strength 0.24
  5. Yukihiko Hiroshima · 7 shared papers, 2013–2014 · strength 0.24
  6. Fuminari Uehara · 6 shared papers, 2013–2014 · strength 0.21
  7. Yohei Asano · 1 shared paper, 2025 · strength 0.20
  8. Motokazu Sato · 1 shared paper, 2024 · strength 0.18
  9. Ali A. Maawy · 5 shared papers, 2013–2014 · strength 0.17
  10. Itaru Endo · 5 shared papers, 2013–2014 · strength 0.17
  11. Takashi Murakami · 3 shared papers, 2014 · strength 0.10
  12. Yasushi Ichikawa · 2 shared papers, 2014 · strength 0.07
  13. Atsushi Suetsugu · 2 shared papers, 2013–2014 · strength 0.07
  14. Mohamed K. Hassanein · 2 shared papers, 2013–2014 · strength 0.06
  15. Matthew H. G. Katz · 1 shared paper, 2014 · strength 0.03
  16. Jason B. Fleming · 1 shared paper, 2014 · strength 0.03
  17. Rhiana S. Menen · 1 shared paper, 2014 · strength 0.03
  18. Ryutaro Mori · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.